Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cannabinoids and pain.

I J Lever1, A S C Rice

  • 1Pain Research Group, Department of Anaesthetics, Intensive Care and Pain Medicine, Imperial College London, Chelsea and Westminster Hospital Campus, 369 Fulham Road, London SW10 9NH, UK.

Handbook of Experimental Pharmacology
|November 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sensory profiles in women with neuropathic pain after breast cancer surgery.

Breast cancer research and treatment·2020
Same author

Experimental design and reporting standards for improving the internal validity of pre-clinical studies in the field of pain: Consensus of the IMI-Europain consortium.

Scandinavian journal of pain·2018
Same author

Flight Lieutenant Peach's observations on Burning Feet Syndrome in Far Eastern Prisoners of War 1942-45.

QJM : monthly journal of the Association of Physicians·2017
Same author

Pain, inflammation and wound healing.

Journal of wound care·2016
Same author

Enhanced c-Fos expression in the central amygdala correlates with increased thigmotaxis in rats with peripheral nerve injury.

European journal of pain (London, England)·2016
Same author

Angiotensin II type 2-receptor: new clinically validated target in the treatment of neuropathic pain.

Clinical pharmacology and therapeutics·2015

Cannabinoids show promise in reducing pain responses in preclinical models by acting on cannabinoid receptors. However, their clinical effectiveness as analgesics requires further high-quality trials and development of better therapeutic options.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Management

Background:

  • Preclinical studies indicate cannabinoids possess analgesic properties.
  • Cannabinoid receptors are involved in pain signal transmission and processing.
  • The exact mechanisms of cannabinoid-induced analgesia are not fully understood.

Purpose of the Study:

  • To review the evidence for cannabinoid-mediated analgesia.
  • To explore the signaling pathways involved in cannabinoid action.
  • To assess the clinical potential of cannabinoids for pain relief.

Main Methods:

  • Review of preclinical studies on cannabinoid analgesia.
  • Analysis of anatomical and functional data on cannabinoid receptor distribution.
  • Examination of intracellular signaling mechanisms associated with cannabinoid receptors.

Related Experiment Videos

Main Results:

  • Cannabinoids reduce pain in various preclinical models.
  • Cannabinoid receptors are located in key areas for pain processing.
  • Intracellular mechanisms like calcium transient inhibition and adenylate cyclase modulation are implicated.

Conclusions:

  • Cannabinoids modulate neuronal and immune cells involved in pain and inflammation.
  • Clinical efficacy of cannabinoids for pain relief remains uncertain.
  • Further research necessitates improved cannabinoid therapeutics and rigorous clinical trials.